Journal of Medicinal Chemistry,
Год журнала:
2024,
Номер
67(11), С. 9091 - 9103
Опубликована: Май 23, 2024
Induction
of
cuproptosis
and
targeting
multiple
signaling
pathways
show
promising
applications
in
tumor
therapy.
In
this
study,
we
synthesized
two
thiosemicarbazone-copper
complexes
([Cu
Drug Resistance Updates,
Год журнала:
2023,
Номер
72, С. 101018 - 101018
Опубликована: Ноя. 11, 2023
Cuproptosis
is
a
newly
identified
form
of
cell
death
driven
by
copper.
Recently,
the
role
copper
and
triggered
in
pathogenesis
cancers
have
attracted
attentions.
has
garnered
enormous
interest
cancer
research
communities
because
its
great
potential
for
therapy.
Copper-based
treatment
exerts
an
inhibiting
tumor
growth
may
open
door
chemotherapy-insensitive
tumors.
In
this
review,
we
provide
critical
analysis
on
homeostasis
dysregulation
development
progression
cancers.
Then
core
molecular
mechanisms
cuproptosis
discussed,
followed
summarizing
current
understanding
copper-based
agents
(copper
chelators,
ionophores,
complexes-based
dynamic
therapy)
treatment.
Additionally,
summarize
emerging
data
ionophores
to
subdue
chemotherapy
resistance
different
types
We
also
review
small-molecule
compounds
nanoparticles
(NPs)
that
kill
cells
inducing
cuproptosis,
which
will
shed
new
light
anticancer
drugs
through
future.
Finally,
important
concepts
pressing
questions
future
should
be
focused
were
discussed.
This
article
suggests
targeting
could
novel
antitumor
therapy
strategy
overcome
drug
resistance.
Frontiers in Oncology,
Год журнала:
2023,
Номер
13
Опубликована: Июнь 23, 2023
As
an
essential
nutrient,
copper’s
redox
properties
are
both
beneficial
and
toxic
to
cells.
Therefore,
leveraging
the
characteristics
of
copper-dependent
diseases
or
using
copper
toxicity
treat
copper-sensitive
may
offer
new
strategies
for
specific
disease
treatments.
In
particular,
concentration
is
typically
higher
in
cancer
cells,
making
a
critical
limiting
nutrient
cell
growth
proliferation.
Hence,
intervening
metabolism
cells
become
potential
tumor
treatment
strategy,
directly
impacting
metastasis.
this
review,
we
discuss
body
summarize
research
progress
on
role
promoting
inducing
programmed
death
Additionally,
elucidate
copper-related
drugs
treatment,
intending
provide
perspectives
treatment.
Immunological Reviews,
Год журнала:
2023,
Номер
321(1), С. 211 - 227
Опубликована: Сен. 16, 2023
Summary
Copper
is
an
essential
nutrient
for
maintaining
enzyme
activity
and
transcription
factor
function.
Excess
copper
results
in
the
aggregation
of
lipoylated
dihydrolipoamide
S‐acetyltransferase
(DLAT),
which
correlates
to
mitochondrial
tricarboxylic
acid
(TCA)
cycle,
resulting
proteotoxic
stress
eliciting
a
novel
cell
death
modality:
cuproptosis.
Cuproptosis
exerts
indispensable
role
cancer
progression,
considered
promising
strategy
therapy.
Cancer
immunotherapy
has
gained
extensive
attention
owing
breakthroughs
immune
checkpoint
blockade;
furthermore,
cuproptosis
strongly
connected
modulation
antitumor
immunity.
Thus,
thorough
recognition
concerning
mechanisms
involved
metabolism
may
facilitate
improvement
management.
This
review
outlines
cellular
molecular
characteristics
links
regulated
modality
with
human
cancers.
We
also
current
knowledge
on
complex
effects
immunity
response.
Furthermore,
potential
agents
that
elicit
pathways
are
summarized.
Lastly,
we
discuss
influence
induction
tumor
microenvironment
as
well
challenges
adding
regulators
therapeutic
strategies
beyond
traditional
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
171, С. 116115 - 116115
Опубликована: Янв. 5, 2024
Ferroptosis
and
cuproptosis,
regulated
forms
of
cell
death
resulting
from
metal
ion
accumulation,
are
closely
related
in
terms
occurrence,
metabolism,
signaling
pathways,
drug
resistance.
Notably,
it
is
now
understood
that
these
processes
play
crucial
roles
regulating
physiological
pathological
processes,
especially
tumor
development.
Consequently,
ferroptosis
cuproptosis
have
gained
increasing
significance
as
potential
targets
for
anti-cancer
This
article
systematically
outlines
the
molecular
mechanisms
cross-talk
components
both
elucidating
their
impacts
on
cancer.
Furthermore,
investigates
clinical
perspective
targeted
cancer
chemotherapy,
immunotherapy,
radiotherapy.
Our
discussion
extends
to
a
comparative
analysis
nanoparticles
developed
based
cancer,
contrasting
them
with
current
conventional
therapies.
Opportunities
challenges
treatment
explored,
emphasizing
therapeutic
direction
co-targeting
cuproptosis.
The
also
attempts
analyze
applications
this
approach
while
summarizing
existing
barriers
require
overcoming.
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(18)
Опубликована: Фев. 23, 2024
Abstract
Single‐atom
nanozyme
(SAzyme)
has
sparked
increasing
interest
for
catalytic
antitumor
treatment
due
to
their
more
tunable
and
diverse
active
sites
than
natural
metalloenzymes
in
complex
physiological
conditions.
However,
it
is
usually
a
hard
task
precisely
conduct
catalysis
at
tumor
after
intravenous
injection
of
those
SAzyme
with
high
reactivity.
Moreover,
the
explorations
SAzymes
anticancer
application
are
still
its
infancy
need
be
developed.
Herein,
an
situ
synthesis
strategy
Cu
was
constructed
convert
adsorbed
copper
ions
into
isolated
atoms
anchored
by
oxygen
(Cu−O
2
/Cu−O
4
)
via
GSH‐responsive
deformability
supports.
Our
results
suggest
that
activation
process
could
further
facilitate
dissociation
consumption
glutathione,
thereby
leading
deposition
cytoplasm
triggering
cuproptosis.
peroxidase‐like
activity
enabled
intracellular
reactive
species
production,
resulting
specifically
disturbance
metabolism
pathway.
Meanwhile,
exposed
glucose
transporter
(GLUT)
inhibitor
phloretin
(Ph)
can
block
glycose
uptake
boost
cuproptosis
efficacy.
Overall,
this
effectively
diminished
off‐target
effects
SACs‐induced
therapies
introduced
promising
paradigm
advancing
cuproptosis‐associated
therapies.
npj Precision Oncology,
Год журнала:
2024,
Номер
8(1)
Опубликована: Фев. 26, 2024
Abstract
Cancer
cell
growth,
metastasis,
and
drug
resistance
pose
significant
challenges
in
the
management
of
lung
adenocarcinoma
(LUAD).
However,
there
is
a
deficiency
optimal
predictive
models
capable
accurately
forecasting
patient
prognoses
guiding
selection
targeted
treatments.
Programmed
death
(PCD)
pathways
play
pivotal
role
development
progression
various
cancers,
offering
potential
as
prognostic
indicators
sensitivity
markers
for
LUAD
patients.
The
validation
were
conducted
by
integrating
13
PCD
patterns
with
comprehensive
analysis
bulk
RNA,
single-cell
RNA
transcriptomics,
pertinent
clinicopathological
details
derived
from
TCGA-LUAD
six
GEO
datasets.
Utilizing
machine
learning
algorithms,
we
identified
ten
critical
differentially
expressed
genes
associated
LUAD,
namely
CHEK2,
KRT18,
RRM2,
GAPDH,
MMP1,
CHRNA5,
TMPRSS4,
ITGB4,
CD79A,
CTLA4.
Subsequently,
programmed
index
(PCDI)
based
on
these
across
aforementioned
cohorts
integrated
this
relevant
clinical
features
to
develop
several
nomograms.
Furthermore,
observed
correlation
between
PCDI
immune
including
infiltration
expression
checkpoint
molecules.
Additionally,
found
that
patients
high
score
may
exhibit
immunotherapy
standard
adjuvant
chemotherapy
regimens;
however,
they
benefit
other
FDA-supported
drugs
such
docetaxel
dasatinib.
In
conclusion,
holds
signature
can
facilitate
personalized
treatment
Current Medical Science,
Год журнала:
2024,
Номер
44(1), С. 28 - 50
Опубликована: Фев. 1, 2024
Abstract
Copper
is
an
essential
trace
element,
and
plays
a
vital
role
in
numerous
physiological
processes
within
the
human
body.
During
normal
metabolism,
body
maintains
copper
homeostasis.
deficiency
or
excess
can
adversely
affect
cellular
function.
Therefore,
homeostasis
stringently
regulated.
Recent
studies
suggest
that
trigger
specific
form
of
cell
death,
namely,
cuproptosis,
which
triggered
by
excessive
levels
intracellular
copper.
Cuproptosis
induces
aggregation
mitochondrial
lipoylated
proteins,
loss
iron-sulfur
cluster
proteins.
In
neurodegenerative
diseases,
pathogenesis
progression
neurological
disorders
are
linked
to
This
review
summarizes
advances
cuproptosis
nervous
system
diseases.
offers
research
perspectives
provide
new
insights
into
targeted
treatment
diseases
based
on
cuproptosis.
Journal of Cancer Research and Clinical Oncology,
Год журнала:
2024,
Номер
150(4)
Опубликована: Апрель 25, 2024
Abstract
Copper
is
a
necessary
micronutrient
for
maintaining
the
well-being
of
human
body.
The
biological
activity
organic
ligands,
especially
their
anticancer
activity,
often
enhanced
when
they
coordinate
with
copper(I)
and
(II)
ions.
its
compounds
are
capable
inducing
tumor
cell
death
through
various
mechanisms
action,
including
activation
apoptosis
signaling
pathways
by
reactive
oxygen
species
(ROS),
inhibition
angiogenesis,
induction
cuproptosis,
paraptosis.
Some
copper
complexes
currently
being
evaluated
in
clinical
trials
ability
to
map
hypoxia
cancers,
locally
advanced
rectal
cancer
bulky
tumors.
Several
studies
have
shown
that
nanoparticles
can
be
used
as
effective
agents
chemodynamic
therapy,
phototherapy,
hyperthermia,
immunotherapy.
Despite
promising
copper-based
compounds,
use
subject
certain
limitations.
Elevated
concentrations
may
promote
growth,
metastasis
affecting
cellular
processes.
Journal of Neuroinflammation,
Год журнала:
2024,
Номер
21(1)
Опубликована: Апрель 22, 2024
Abstract
Background
Postoperative
cognitive
dysfunction
(POCD)
is
a
common
neurological
complication
of
anesthesia
and
surgery
in
aging
individuals.
Neuroinflammation
has
been
identified
as
hallmark
POCD.
However,
safe
effective
treatments
POCD
are
still
lacking.
Itaconate
an
immunoregulatory
metabolite
derived
from
the
tricarboxylic
acid
cycle
that
exerts
anti-inflammatory
effects
by
activating
nuclear
factor
erythroid
2-related
2
(Nrf2)
pathway.
In
this
study,
we
investigated
underlying
mechanism
4-octyl
itaconate
(OI),
cell-permeable
derivative,
on
aged
mice.
Methods
A
animal
model
was
established
performing
aseptic
laparotomy
18-month-old
male
C57BL/6
mice
under
isoflurane
while
maintaining
spontaneous
ventilation.
OI
intraperitoneally
injected
into
after
surgery.
Primary
microglia
neurons
were
isolated
treated
to
lipopolysaccharide
(LPS),
isoflurane,
OI.
Cognitive
function,
neuroinflammatory
responses,
well
levels
gut
microbiota
their
metabolites
evaluated.
To
determine
mechanisms
therapeutic
POCD,
ML385,
antagonist
Nrf2,
administered
intraperitoneally.
endogenous
neurogenesis,
neuronal
apoptosis,
Nrf2/extracellular
signal-related
kinases
(ERK)
signaling
pathway
Results
Our
findings
revealed
treatment
significantly
alleviated
anesthesia/surgery-induced
impairment,
concomitant
with
reduced
cytokines
IL-1β
IL-6,
suppressed
activation
astrocytes
hippocampus.
Similarly,
inhibited
expression
IL-6
LPS
isoflurane-induced
primary
vitro.
Intraperitoneal
administration
led
alterations
promoted
production
microbiota-derived
associated
neurogenesis.
We
further
confirmed
neurogenesis
apoptosis
hippocampal
dentate
gyrus
Mechanistically,
observed
decrease
Nrf2
both
vitro
vivo,
which
reversed
treatment.
found
required
for
inhibit
neuroinflammation
The
enhanced
recovery
promotion
triggered
exposure
were,
at
least
partially,
mediated
Nrf2/ERK
Conclusions
demonstrate
can
attenuate
impairment
stabilizing
restrict
promote
Boosting
or
supplementation
exogenous
derivatives
may
represent
novel
strategies